ArticleBMC microbiology2025
Exploring the interactome of the Staphylococcus aureus sRNA Srn_9342 identified a complex formation with RNAIII leading to the modulation of δ-hemolysin expression.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStaphylococcus aureus is a major pathogen responsible for a variety of infections. It expresses a wide range of factors to precisely coordinate gene expression in response to the ever-changing conditions. Among them, regulatory RNAs appear as key players of post-transcriptional and translational regulations. Here, we investigated the role of Srn_9342, a sRNA candidate previously identified in a cluster of five srna genes in Newman strain.
resultsWe showed that Srn_9342 is expressed under two isoforms of different lengths (Srn_9342S and Srn_9342L) whose transcript levels are divergent as a function of growth phase with Srn_9342S being expressed at low cell-density, then being substituted by Srn_9342L at high cell-density. Using MS2-Affinity Purification Coupled with RNA Sequencing, we searched for RNA molecular partners of both Srn_9342S and Srn_9342L. Interestingly, we found that Srn_9342S was mainly bound to sRNAs whereas the expression of Srn_9342L led to the enrichment of mRNAs often linked with transport and metabolism. Among the sRNAs identified, the master regulator of virulence RNAIII appeared as an attractive partner. Using various constructs, we showed that the 5’ end of Srn_9342 specifically binds the 3’ end of RNAIII with high affinity in vitro, and that Srn_9342 mitigate RNAIII transcript level and stability. Finally, we report that the deletion of srn_9342 modulates the expression of the RNAIII encoded toxin δ-hemolysin and hemolytic activity, suggesting that the binding of Srn_9342 onto RNAIII may induce structural changes of RNAIII, and hence expression of the toxin.
conclusionsOverall, we showed that Srn_9342 has an unusual pattern of expression and that uncovering its targetome suggests a potential role in S. aureus virulence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.